Related Experiment Video
Updated: May 5, 2026
10:21
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
9.9K
[Vascular functional alterations in hypertrophic cardiomyopathy]
1Szegedi Tudományegyetem, Szent-Györgyi Albert Klinikai Központ, Általános Orvostudományi Kar II. Belgyógyászati Klinika és Kardiológiai Központ Szeged Korányi fasor 6. 6720.
Orvosi Hetilap
|November 19, 2013
Summary
Hypertrophic cardiomyopathy, a genetic heart muscle disorder, involves abnormal interventricular septum thickening. This review focuses on the associated vascular functional alterations in hypertrophic cardiomyopathy patients.
Area of Science:
- Cardiology
- Genetics
- Vascular Biology
Context:
- Hypertrophic cardiomyopathy (HCM) is a prevalent hereditary cardiac condition characterized by asymmetric interventricular septal thickening.
- While primarily viewed as a myocardial disorder, HCM is increasingly recognized to involve significant vascular abnormalities.
Purpose:
- To comprehensively review and synthesize the current understanding of vascular functional alterations in hypertrophic cardiomyopathy.
- To highlight the role of vascular dysfunction in the pathophysiology of HCM.
Summary:
- The review consolidates findings on altered vascular structure and function in HCM, extending beyond the primary cardiac muscle pathology.
- Specific vascular changes discussed include endothelial dysfunction, microvascular alterations, and potential impacts on myocardial perfusion.
Impact:
- Provides a consolidated resource for researchers and clinicians investigating HCM.
- May inform future diagnostic strategies and therapeutic targets for managing vascular complications in hypertrophic cardiomyopathy.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
810
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
01:29Heart Failure II: Pathophysiology
2.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K
01:17Pathophysiology of Heart Failure
5.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
5.1K
01:29Cardiomyopathy V: Interprofessional Care
761
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761
01:26Cellular Adaptation II: Hypertrophy
78
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy:...
78
01:30Cardiomyopathy II: Dilated Cardiomyopathy
798
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798